These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28597184)

  • 1. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
    Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
    J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
    Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
    Chang HH; Cheng YC; Tsai WC; Chen Y
    Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
    Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
    J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
    Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
    Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines.
    Sun M; Cherian N; Liu L; Chan AM; Aguirre B; Chu A; Strawbridge J; Kim ES; Lin MC; Tsui I; Gordon LK; Wadehra M
    Sci Rep; 2022 Nov; 12(1):19432. PubMed ID: 36371458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2.
    Lin M; Zhang X; Jia B; Guan S
    J Neurooncol; 2018 Jan; 136(2):243-254. PubMed ID: 29116484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.
    Hong XY; Wang J; Li Z
    Cell Biochem Biophys; 2013; 67(3):1487-95. PubMed ID: 23712868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
    Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
    Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
    Zhang J; Xue W; Xu K; Yi L; Guo Y; Xie T; Tong H; Zhou B; Wang S; Li Q; Liu H; Chen X; Fang J; Zhang W
    Theranostics; 2020; 10(16):7245-7259. PubMed ID: 32641990
    [No Abstract]   [Full Text] [Related]  

  • 12. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.
    Gordon LK; Kiyohara M; Fu M; Braun J; Dhawan P; Chan A; Goodglick L; Wadehra M
    Oncogene; 2013 Nov; 32(46):5369-76. PubMed ID: 23334331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMP2 is a novel therapeutic target for endometrial cancer stem cells.
    Kiyohara MH; Dillard C; Tsui J; Kim SR; Lu J; Sachdev D; Goodglick L; Tong M; Torous VF; Aryasomayajula C; Wang W; Najafzadeh P; Gordon LK; Braun J; McDermott S; Wicha MS; Wadehra M
    Oncogene; 2017 Oct; 36(42):5793-5807. PubMed ID: 28604744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells.
    Pai FC; Huang HW; Tsai YL; Tsai WC; Cheng YC; Chang HH; Chen Y
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
    Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM).
    Demeure K; Fack F; Duriez E; Tiemann K; Bernard A; Golebiewska A; Bougnaud S; Bjerkvig R; Domon B; Niclou SP
    Mol Cell Proteomics; 2016 Feb; 15(2):481-92. PubMed ID: 26243272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
    Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
    Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
    Rong X; Huang B; Qiu S; Li X; He L; Peng Y
    Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
    Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
    Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.